Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992 · see citing works

A Receptor-Mediated Pathway for Cholesterol Homeostasis

Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703 · see citing works

Regulation of the mevalonate pathway

Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394 · see citing works

The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA

Yamamoto, T., Davis, C. G., Brown, M. S., Schneider, W. J., Casey, M. L., Goldstein, J. L., & Russell, D. W. (1984) · Cell · doi:10.1016/0092-8674(84)90188-0 · Cited by 1,382 · see citing works

A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood

Brown, M. S., & Goldstein, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11041 · Cited by 1,327 · see citing works

Effect of Statins on Risk of Coronary Disease: A Meta-analysis of Randomized Controlled Trials

LaRosa, J. C., He, J., & Vupputuri, S. (1999) · JAMA · doi:10.1001/jama.282.24.2340 · Cited by 1,246 · see citing works

National Cholesterol Education Program

Lenfant, C. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400060019005 · Cited by 1,184 · see citing works

SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis

Wang, X., Sato, R., Brown, M. S., Hua, X., & Goldstein, J. L. (1994) · Cell · doi:10.1016/0092-8674(94)90234-8 · Cited by 1,003 · see citing works

SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene

Yokoyama, C., Wang, X., Briggs, M. R., Admon, A., Wu, J., Hua, X., Goldstein, J. L., & Brown, M. S. (1993) · Cell · doi:10.1016/s0092-8674(05)80095-9 · Cited by 968 · see citing works

Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence

Briggs, M. R., Yokoyama, C., Wang, X., Brown, M. S., & Goldstein, J. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85265-1 · Cited by 401 · see citing works

Post-transcriptional Control of Cyclooxygenase-2 Gene Expression

Dixon, D. A., Kaplan, C. D., McIntyre, T. M., Zimmerman, G. A., & Prescott, S. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.11750 · Cited by 348 · see citing works

Regulated Step in Cholesterol Feedback Localized to Budding of SCAP from ER Membranes

Nohturfft, A., Yabe, D., Goldstein, J. L., Brown, M. S., & Espenshade, P. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00037-4 · Cited by 347 · see citing works

Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. II. Purification and characterization

Wang, X., Briggs, M. R., Hua, X., Yokoyama, C., Goldstein, J. L., & Brown, M. S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85266-3 · Cited by 299 · see citing works

Cardiovascular actions of berberine

Lau, C., Yao, X., Chen, Z., Ko, W., & Huang, Y. (2001) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2001.tb00068.x · Cited by 281 · see citing works

Mutant Mammalian Cells as Tools to Delineate the Sterol Regulatory Element-Binding Protein Pathway for Feedback Regulation of Lipid Synthesis

Goldstein, J. L., Rawson, R. B., & Brown, M. S. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2615 · Cited by 250 · see citing works

Sterols regulate cycling of SREBP cleavage-activating protein (SCAP) between endoplasmic reticulum and Golgi

Nohturfft, A., DeBose‐Boyd, R. A., Scheek, S., Goldstein, J. L., & Brown, M. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11235 · Cited by 244 · see citing works

Identification of nucleotides responsible for enhancer activity of sterol regulatory element in low density lipoprotein receptor gene.

Smith, J. R., Osborne, T. F., Goldstein, J. L., & Brown, M. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39976-4 · Cited by 236 · see citing works

Statin Trials and Goals of Cholesterol-Lowering Therapy

Grundy, S. M. (1998) · Circulation · doi:10.1161/01.cir.97.15.1436 · Cited by 197 · see citing works

Effect of Statins on Risk of Coronary Disease: A Meta-analysis of Randomized Controlled Trials

LaRosa, J. C., He, J., & Vupputuri, S. X. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200012000-00024 · Cited by 157 · see citing works

An Evidence-Based Assessment of the NCEP Adult Treatment Panel II Guidelines

Ansell, B., Watson, K., & Fogelman, A. (1999) · JAMA · doi:10.1001/jama.282.21.2051 · Cited by 102 · see citing works

Dietary fatty acids regulate hepatic low density lipoprotein (LDL) transport by altering LDL receptor protein and mRNA levels.

Horton, J. D., Cuthbert, J. A., & Spady, D. K. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116645 · Cited by 100 · see citing works

Bile Acids Enhance Low Density Lipoprotein Receptor Gene Expression via a MAPK Cascade-mediated Stabilization of mRNA

Nakahara, M., Fujii, H., Maloney, P., Shimizu, M., & Sato, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206749200 · Cited by 93 · see citing works

Overexpression of Membrane Domain of SCAP Prevents Sterols from Inhibiting SCAP·SREBP Exit from Endoplasmic Reticulum

Yang, T., Goldstein, J. L., & Brown, M. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005439200 · Cited by 87 · see citing works

Feedback regulation of MAPK signalling by an RNA-binding protein

Sugiura, R., Kita, A., Shimizu, Y., Shuntoh, H., Sio, S. O., & Kuno, T. (2003) · Nature · doi:10.1038/nature01907 · Cited by 86 · see citing works

The sterol regulatory element-binding protein pathway: control of lipid homeostasis through regulated intracellular transport

Sakai, J., & Rawson, R. B. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00004 · Cited by 73 · see citing works

ONCOSTATIN M-SPECIFIC RECEPTOR EXPRESSION AND FUNCTION IN REGULATING CELL PROLIFERATION OF NORMAL AND MALIGNANT MAMMARY EPITHELIAL CELLS

Liu, J., Hadjokas, N. E., Mosley, B., Estrov, Z., Spence, M. J., & Vestal, R. E. (1998) · Cytokine · doi:10.1006/cyto.1997.0283 · Cited by 72 · see citing works

SCAP ligands are potent new lipid-lowering drugs

Grand‐Perret, T., Bouillot, A., Perrot, A., Commans, S., Walker, M., & Issandou, M. (2001) · Nature Medicine · doi:10.1038/nm1201-1332 · Cited by 61 · see citing works

Stabilization and cytoskeletal-association of LDL receptor mRNA are mediated by distinct domains in its 3′ untranslated region

Wilson, G. M., Vasa, M. Z., & Deeley, R. G. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33870-0 · Cited by 58 · see citing works

Identification of a Novel Sterol-independent Regulatory Element in the Human Low Density Lipoprotein Receptor Promoter

Liu, J., Ahlborn, T. E., Briggs, M. R., & Kraemer, F. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.5214 · Cited by 54 · see citing works

Statin Therapy

Yeung, A. C., & Tsao, P. S. (2002) · Circulation · doi:10.1161/01.cir.0000023397.12047.03 · Cited by 42 · see citing works

Novel mechanism of transcriptional activation of hepatic LDL receptor by oncostatin M

Liu, J., Streiff, R. J., Zhang, Y. L., Vestal, R. E., Spence, M. J., & Briggs, M. R. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37134-0 · Cited by 40 · see citing works

Doubling Expression of the Low Density Lipoprotein Receptor by Truncation of the 3′-Untranslated Region Sequence Ameliorates Type III Hyperlipoproteinemia in Mice Expressing the Human ApoE2 Isoform

Knouff, C. W., Malloy, S. I., Wilder, J., Altenburg, M. K., & Maeda, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009423200 · Cited by 36 · see citing works

Identification of Egr1 as the oncostatin M-induced transcription activator that binds to sterol-independent regulatory element of human LDL receptor promoter

Zhang, F., Ahlborn, T. E., Li, C., Kraemer, F. B., & Liu, J. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200126-jlr200 · Cited by 23 · see citing works

Synergistic Activation of Human LDL Receptor Expression by SCAP Ligand and Cytokine Oncostatin M

Liu, J., Zhang, F., Li, C., Lin, M., & Briggs, M. R. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000046229.77566.e5 · Cited by 20 · see citing works

Effect of YM‐53601, a novel squalene synthase inhibitor, on the clearance rate of plasma LDL and VLDL in hamsters

Ugawa, T., Kakuta, H., Moritani, H., & Inagaki, O. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704906 · Cited by 18 · see citing works

Effects of LY295427, a Low-Density Lipoprotein (LDL) Receptor Up-Regulator, on LDL Receptor Gene Transcription and Cholesterol Metabolism in Normal and Hypercholesterolemic Hamsters

Bensch, W. R., Gadski, R. A., Bean, J. S., Beavers, L. S., Schmidt, R. J., Perry, D. N., Murphy, A., McClure, D., Eacho, P. I., Breau, A. P., et al. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38110-8 · Cited by 16 · see citing works

AMPK in Health and Disease

Steinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,633 · see citing works

Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States

Lee, Y. S., Kim, W. S., Kim, K. H., Yoon, M. J., Cho, H. J., Shen, Y., Ye, J.-M., Lee, C. H., Oh, W. K., Kim, C. T., et al. (2006) · Diabetes · doi:10.2337/db06-0006 · Cited by 1,054 · see citing works

Efficacy of berberine in patients with type 2 diabetes mellitus

Yin, J., Xing, H., & Ye, J. (2008) · Metabolism · doi:10.1016/j.metabol.2008.01.013 · Cited by 801 · see citing works

Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine

Imanshahidi, M., & Hosseinzadeh, H. (2008) · Phytotherapy Research · doi:10.1002/ptr.2399 · Cited by 636 · see citing works

Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats

Zhang, X., Zhao, Y., Xu, J., Xue, Z., Zhang, M., Pang, X., Zhang, X., & Zhao, L. (2015) · Scientific Reports · doi:10.1038/srep14405 · Cited by 630 · see citing works

Structural Changes of Gut Microbiota during Berberine-Mediated Prevention of Obesity and Insulin Resistance in High-Fat Diet-Fed Rats

Zhang, X., Zhao, Y., Zhang, M., Pang, X., Xu, J., Kang, C., Li, M., Zhang, C., Zhang, Z., Zhang, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042529 · Cited by 615 · see citing works

Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine

Zhang, Y., Li, X., Zou, D., Liu, W., Yang, J., Zhu, N., Huo, L., Wang, M., Hong, J., Wu, P., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2404 · Cited by 573 · see citing works

Berberine and Its More Biologically Available Derivative, Dihydroberberine, Inhibit Mitochondrial Respiratory Complex I

Turner, N., Li, J.-Y., Gosby, A., To, S. W. C., Cheng, Z., Miyoshi, H., Taketo, M. M., Cooney, G. J., Kraegen, E. W., James, D. E., et al. (2008) · Diabetes · doi:10.2337/db07-1552 · Cited by 535 · see citing works

Biological properties and clinical applications of berberine

Song, D., Hao, J., & Fan, D. (2020) · Frontiers of Medicine · doi:10.1007/s11684-019-0724-6 · Cited by 510 · see citing works

Berberine and Coptidis Rhizoma as novel antineoplastic agents: A review of traditional use and biomedical investigations

Tang, J., Feng, Y., Tsao, S., Wang, N., Curtain, R., & Wang, Y. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.08.009 · Cited by 491 · see citing works

Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics

Feng, X., Sureda, A., Jafari, S., Memariani, Z., Tewari, D., Annunziata, G., Barrea, L., Hassan, S. T. S., Šmejkal, K., Malaník, M., et al. (2019) · Theranostics · doi:10.7150/thno.30787 · Cited by 465 · see citing works

Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension

Lan, J., Zhao, Y., Dong, F., Yan, Z., Zheng, W., Fan, J., & Sun, G. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.09.049 · Cited by 458 · see citing works

Berberine suppresses proinflammatory responses through AMPK activation in macrophages

Jeong, H. W., Hsu, K. C., Lee, J.-W., Ham, M., Huh, J. Y., Shin, H. J., Kim, W. S., & Kim, J. B. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90599.2008 · Cited by 454 · see citing works

The Crosstalk Between Nrf2 and AMPK Signal Pathways Is Important for the Anti-Inflammatory Effect of Berberine in LPS-Stimulated Macrophages and Endotoxin-Shocked Mice

Mo, C., Wang, L., Zhang, J., Numazawa, S., Tang, H. W., Tang, X., Han, X., Li, J., Yang, M., Wang, Z., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5116 · Cited by 442 · see citing works

Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression

Zhang, H., Wei, J., Xue, R., Wu, J.-D., Zhao, W., Wang, Z., Wang, S., Zhou, Z.-X., Song, D., Wang, Y., et al. (2009) · Metabolism · doi:10.1016/j.metabol.2009.07.029 · Cited by 442 · see citing works

Berberine activates thermogenesis in white and brown adipose tissue

Zhang, Z., Zhang, H., Li, B., Meng, X.-J., Wang, J., Zhang, Y., Yao, S., Ma, Q., Jin, L., Yang, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6493 · Cited by 439 · see citing works

AMPK activation: a therapeutic target for type 2 diabetes?

Saha, A. K., Coughlan, K. A., Valentine, R. J., & Ruderman, N. B. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s43731 · Cited by 440 · see citing works

New opportunities and challenges of natural products research: When target identification meets single-cell multiomics

Zhu, Y., Ouyang, Z., Du, H., Wang, M., Wang, J., Sun, H., Kong, L., Xu, Q., Ma, H., & Sun, Y. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.08.022 · Cited by 422 · see citing works

Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment

Maxwell, K. N., Fisher, E. A., & Breslow, J. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409736102 · Cited by 415 · see citing works

The landscape of aging

Cai, Y., Song, W., Li, J., Jing, Y., Liang, C., Zhang, L., Zhang, X., Zhang, W., Liu, B., An, Y., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2161-3 · Cited by 436 · see citing works

Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward?

Patwardhan, B., & Mashelkar, R. A. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.05.009 · Cited by 390 · see citing works

Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)

Zhang, Y., Gu, Y., Ren, H., Wang, S., Zhong, H., Zhao, X., Ma, J., Gu, X., Xue, Y., Huang, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18414-8 · Cited by 380 · see citing works

Gut microbiota, a new frontier to understand traditional Chinese medicines

Feng, W., Ao, H., Peng, C. Y., & Yan, D. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.02.024 · Cited by 379 · see citing works

Analysis of alkaloids (indole alkaloids, isoquinoline alkaloids, tropane alkaloids)

Dey, P. K., Kundu, A. B., Kumar, A., Gupta, M., Lee, B. M., Bhakta, T., Dash, S., & Kim, H. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816455-6.00015-9 · Cited by 403 · see citing works

Traditional Chinese Medicine in Treatment of Metabolic Syndrome

Yin, J., Zhang, H., & Ye, J. (2008) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153008784534330 · Cited by 374 · see citing works

Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders

Kulkarni, S. K., & Dhir, A. (2009) · Phytotherapy Research · doi:10.1002/ptr.2968 · Cited by 367 · see citing works

Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats

Chen, W., Miao, Y.-Q., Fan, D.-J., Yang, S.-S., Lin, X., Meng, L.-K., & Tang, X. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9632-z · Cited by 363 · see citing works

Research progress on berberine with a special focus on its oral bioavailability

Liu, C.-S., Zheng, Y.-R., Zhang, Y.-F., & Long, X.-Y. (2016) · Fitoterapia · doi:10.1016/j.fitote.2016.02.001 · Cited by 363 · see citing works

Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats

Liu, Y.-T., Hao, H.-P., Xie, H.-G., Lai, L., Wang, Q., Liu, C.-X., & Wang, G.-J. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.033936 · Cited by 356 · see citing works

Molecular Insights and Therapeutic Targets for Diabetic Endothelial Dysfunction

Xu, J., & Zou, M. (2009) · Circulation · doi:10.1161/circulationaha.108.835223 · Cited by 348 · see citing works

Berberine pharmacology and the gut microbiota: A hidden therapeutic link

Habtemariam, S. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104722 · Cited by 352 · see citing works

Nutraceuticals and dyslipidaemia: Beyond the common therapeutics

Scicchitano, P., Cameli, M., Maiello, M. R., Modesti, P. A., Muiesan, M. L., Novo, S., Palmiero, P., Saba, P. S., Pedrinelli, R., & Ciccone, M. M. (2014) · Journal of Functional Foods · doi:10.1016/j.jff.2013.12.006 · Cited by 351 · see citing works

Hepatocyte Nuclear Factor 1α Plays a Critical Role in PCSK9 Gene Transcription and Regulation by the Natural Hypocholesterolemic Compound Berberine

Li, H., Dong, B., Park, S. W., Lee, H.-S., Chen, W., & Liu, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.052407 · Cited by 349 · see citing works

Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine

Brusq, J.-M. G., Ancellin, N., Grondin, P., Guillard, R., Martin, S., Saintillan, Y., & Issandou, M. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600020-jlr200 · Cited by 344 · see citing works

Microbial production of plant benzylisoquinoline alkaloids

Minami, H., Kim, J., Ikezawa, N., Takemura, T., Katayama, T., Kumagai, H., & Sato, F. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802981105 · Cited by 340 · see citing works

Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota

Wang, Y., Tong, Q., Ma, S.-R., Zhao, Z.-X., Pan, L.-B., Cong, L., Han, P., Peng, R., Yu, H., Lin, Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00456-5 · Cited by 319 · see citing works

Berberine: a potential phytochemical with multispectrum therapeutic activities

Vuddanda, P. R., Chakraborty, S., & Singh, S. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.517745 · Cited by 317 · see citing works

The strategies and techniques of drug discovery from natural products

Zhang, L., Song, J., Kong, L., Yuan, T., Li, W., Zhang, W., Hou, B., Lü, Y., & Du, G. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107686 · Cited by 319 · see citing works

Transforming berberine into its intestine-absorbable form by the gut microbiota

Feng, R., Shou, J.-W., Zhao, Z.-X., He, C.-Y., Ma, C., Huang, M., Fu, J., Tan, X.-S., Li, X.-Y., Wen, B.-Y., et al. (2015) · Scientific Reports · doi:10.1038/srep12155 · Cited by 307 · see citing works

Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies

Pirillo, A., & Catapano, A. L. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.09.032 · Cited by 308 · see citing works

Therapeutic potential of nucleic acid‐binding isoquinoline alkaloids: Binding aspects and implications for drug design

Bhadra, K., & Kumar, G. S. (2010) · Medicinal Research Reviews · doi:10.1002/med.20202 · Cited by 308 · see citing works

Nutraceuticals: A paradigm of proactive medicine

Santini, A., Tenore, G. C., & Novellino, E. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.09.003 · Cited by 294 · see citing works

Inhibition of inflammation by berberine: Molecular mechanism and network pharmacology analysis

Wang, K., Yin, J., Chen, J., Ma, J., Si, H., & Xia, D. (2024) · Phytomedicine · doi:10.1016/j.phymed.2023.155258 · Cited by 301 · see citing works

Berberine and Its Role in Chronic Disease

Cicero, A. F. G., & Baggioni, A. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-41334-1_2 · Cited by 285 · see citing works

Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARγ pathway

Huang, C., Zhang, Y., Gong, Z., Sheng, X., Li, Z., Zhang, W., & Qin, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.095 · Cited by 277 · see citing works

Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway

Zhu, X., Bian, H., Wang, L., Sun, X., Xu, X., Yan, H., Xia, M., Chang, X., Lü, Y., Li, Y., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.06.019 · Cited by 274 · see citing works

Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model

Durairajan, S. S. K., Liu, L.-F., Lu, J.-H., Chen, L.-L., Yuan, Q., Chung, S. K., Huang, L., Li, X.-S., Huang, J.-D., & Li, M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.02.016 · Cited by 271 · see citing works

Tissue Distribution of Berberine and Its Metabolites after Oral Administration in Rats

Tan, X.-S., Ma, J.-Y., Feng, R., Ma, C., Chen, W.-J., Sun, Y.-P., Fu, J., Huang, M., He, C.-Y., Shou, J.-W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077969 · Cited by 266 · see citing works

Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression

Kong, W., Zhang, H., Song, D., Xue, R., Zhao, W., Wei, J., Wang, Y., Shan, N., Zhou, Z., Yang, P., et al. (2008) · Metabolism · doi:10.1016/j.metabol.2008.08.013 · Cited by 266 · see citing works

Strong induction of PCSK9 gene expression through HNF1α and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters

Dong, B., Wu, M., Li, H., Kraemer, F. B., Adeli, K., Seidah, N. G., Park, S. W., & Liu, J. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m003566 · Cited by 266 · see citing works

Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis

Xia, X., Yan, J., Shen, Y., Tang, K., Yin, J., Zhang, Y., Yang, D., Liang, H., Ye, J., & Weng, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016556 · Cited by 262 · see citing works

Berberine Targets Assembly of Escherichia coli Cell Division Protein FtsZ

Domadia, P. N., Bhunia, A., Sivaraman, J., Swarup, S., & Dasgupta, D. (2008) · Biochemistry · doi:10.1021/bi7018546 · Cited by 253 · see citing works

Application of Berberine on Treating Type 2 Diabetes Mellitus

Pang, B., Zhao, L., Zhou, Q., Zhao, T., Wang, H., Gu, C., & Tong, X. (2015) · International Journal of Endocrinology · doi:10.1155/2015/905749 · Cited by 254 · see citing works

Engineering microbial factories for synthesis of value-added products

Du, J., Shao, Z., & Zhao, H. (2011) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-011-0970-3 · Cited by 246 · see citing works

Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion

Méndez-del Villar, M., González-Ortiz, M., Martínez-Abundis, E., Pérez-Rubio, K. G., & Lizárraga-Valdez, R. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0082 · Cited by 246 · see citing works

The influence of the gut microbiota on the bioavailability of oral drugs

Zhang, X., Han, Y., Huang, W., Jin, M., & Gao, Z. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.09.013 · Cited by 246 · see citing works

AMP-activated protein kinase, stress responses and cardiovascular diseases

Wang, S., Song, P., & Zou, M. (2012) · Clinical Science · doi:10.1042/cs20110625 · Cited by 243 · see citing works

Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe−/− mice

Zhu, L., Zhang, D., Zhu, H., Zhu, J., Weng, S., Dong, L., Liu, T., Hu, Y., & Shen, X. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.11.023 · Cited by 243 · see citing works

Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence

Xu, X., Yi, H., Wu, J., Kuang, T., Zhang, J., Li, Q., Du, H., Xu, T., Jiang, G., & Fan, G. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110984 · Cited by 246 · see citing works

Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity

Kim, W. S., Lee, Y. S., Cha, S. H., Jeong, H. W., Choe, S. S., Lee, M., Oh, G. T., Park, H., Lee, K., Lane, M. D., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90710.2008 · Cited by 239 · see citing works

Acute toxicity of berberine and its correlation with the blood concentration in mice

Kheir, M. M., Wang, Y., Hua, L., Hu, J., Li, L., Lei, F., & Du, L. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2010.01.033 · Cited by 235 · see citing works

Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease

Yan, H., Xia, M., Wang, Y., Chang, X., Yao, X., Rao, S., Zeng, M., Tu, Y., Feng, R., Jia, W., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134172 · Cited by 233 · see citing works

Berberine decreases PCSK9 expression in HepG2 cells

Cameron, J., Ranheim, T., Kulseth, M. A., Leren, T. P., & Berge, K. E. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.02.004 · Cited by 232 · see citing works

The Anti-Cancer Mechanisms of Berberine: A Review

Wang, Y., Liu, Y., Du, X., Ma, H., & Yao, J. (2020) · Cancer Management and Research · doi:10.2147/cmar.s242329 · Cited by 238 · see citing works

Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products

Wang, D., Yang, Y., Lei, Y., Tzvetkov, N. T., Liu, X., Yeung, A. W. K., Xu, S., & Atanasov, A. G. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017178 · Cited by 223 · see citing works

Berberine in the treatment of type 2 diabetes mellitus: A systemic review and meta-analysis

Dong, H., Wang, N., Zhao, L., & Lu, F. (2012) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2012/591654 · Cited by 225 · see citing works

Functional foods and dietary supplements for the management of dyslipidaemia

Hunter, P. M., & Hegele, R. A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.210 · Cited by 226 · see citing works

Herbal drug discovery for the treatment of nonalcoholic fatty liver disease

Yan, T., Yan, N., Wang, P., Xia, Y., Hao, H., Wang, G., & Gonzalez, F. J. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.11.017 · Cited by 225 · see citing works

TNFα-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFκB signaling

Amasheh, M., Fromm, A., Krug, S. M., Amasheh, S., Andres, S., Zeitz, M., Fromm, M., & Schulzke, J. (2010) · Journal of Cell Science · doi:10.1242/jcs.070896 · Cited by 224 · see citing works

On the mechanism of antidepressant-like action of berberine chloride

Kulkarni, S. K., & Dhir, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.05.043 · Cited by 223 · see citing works

Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine

Singh, S., Pathak, N., Fatima, E., & Negi, A. S. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113839 · Cited by 221 · see citing works

Berberine and neurodegeneration: A review of literature

Ahmed, T., Gilani, A. H., Abdollahi, M. R., Daglia, M., Nabavi, S. F., & Nabavi, S. M. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.03.002 · Cited by 210 · see citing works

Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses

Varghese, F. S., Kaukinen, P., Gläsker, S., Bespalov, M. M., Hanski, L. L., Wennerberg, K., Kümmerer, B. M., & Ahola, T. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2015.12.012 · Cited by 209 · see citing works

Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats

Zhou, J., Zhou, S., Tang, J., Zhang, K., Guang, L.-X., Huang, Y., Xu, Y. X., Ying, Y., Zhang, L., & Li, D. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.12.056 · Cited by 208 · see citing works

Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism

Wang, Y., Shou, J., Li, X., Zhao, Z., Fu, J., He, C., Feng, R., Ma, C., Wen, B., Guo, F., et al. (2017) · Metabolism · doi:10.1016/j.metabol.2017.02.003 · Cited by 206 · see citing works

Nobiletin Attenuates VLDL Overproduction, Dyslipidemia, and Atherosclerosis in Mice With Diet-Induced Insulin Resistance

Mulvihill, E. E., Assini, J. M., Lee, J. K., Allister, E. M., Sutherland, B. G., Koppes, J. B., Sawyez, C. G., Edwards, J. Y., Telford, D. E., Charbonneau, A., et al. (2011) · Diabetes · doi:10.2337/db10-0589 · Cited by 202 · see citing works

Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE−/− Mice

Wu, M., Yang, S., Wang, S., Cao, Y., Zhao, R., Li, X., Xing, Y., & Liu, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00223 · Cited by 201 · see citing works

Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review

Xiong, R.-G., Huang, S., Wu, S.-X., Zhou, D.-D., Yang, Z., Saimaiti, A., Zhao, C., Shang, A., Zhang, Y., Gan, R., et al. (2022) · Molecules · doi:10.3390/molecules27144523 · Cited by 204 · see citing works

Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway

Sun, R., Yang, N., Kong, B., Cao, B., Feng, D., Yu, X., Ge, C., Huang, J., Shen, J., Wang, P., et al. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.106617 · Cited by 199 · see citing works

Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease

Zhu, F., & Qian, C. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-78 · Cited by 197 · see citing works

Berberine Differentially Modulates the Activities of ERK, p38 MAPK, and JNK to Suppress Th17 and Th1 T Cell Differentiation in Type 1 Diabetic Mice

Cui, G., Qin, X., Zhang, Y., Gong, Z., Ge, B., & Zang, Y. Q. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.012674 · Cited by 197 · see citing works

Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota

Ma, S., Tong, Q., Lin, Y., Pan, L., Fu, J., Peng, R., Zhang, X., Zhao, Z., Li, Y., Yu, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01027-6 · Cited by 193 · see citing works

Lipid-modifying effects of nutraceuticals: An evidence-based approach

Sahebkar, A., Șerban, M.-C., Gluba-Brzózka, A., Mikhailidis, D. P., Cicero, A. F. G., Rysz, J., & Banach, M. (2016) · Nutrition · doi:10.1016/j.nut.2016.04.007 · Cited by 188 · see citing works

Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): From bench to bedside

Bao, X., Liang, Y., Chang, H., Cai, T., Feng, B., Gordon, K., Zhu, Y., Shi, H., He, Y., & Xie, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01690-3 · Cited by 187 · see citing works

Nutraceutical therapies for atherosclerosis

Moss, J. W. E., & Ramji, D. P. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.103 · Cited by 186 · see citing works

Berberine stimulates glucose transport through a mechanism distinct from insulin

Zhou, L., Yang, Y., Wang, X., Liu, S., Shang, W., Yuan, G., Li, F., Tang, J., Chen, M., & Chen, J. (2007) · Metabolism · doi:10.1016/j.metabol.2006.10.025 · Cited by 187 · see citing works

Berberine alters the processing of Alzheimer’s amyloid precursor protein to decrease Aβ secretion

Asai, M., Iwata, N., Yoshikawa, A., Aizaki, Y., Ishiura, S., Saido, T. C., & Maruyama, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.11.043 · Cited by 182 · see citing works

Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice

Peng, W., Lo, K.-L., Lee, Y.-H., Hung, T.-H., & Lin, Y.-C. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.08.003 · Cited by 183 · see citing works

Effects and Action Mechanisms of Berberine and Rhizoma coptidis on Gut Microbes and Obesity in High-Fat Diet-Fed C57BL/6J Mice

Xie, W., Gu, D., Li, J., Cui, K., & Zhang, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024520 · Cited by 183 · see citing works

Identification of a WRKY Protein as a Transcriptional Regulator of Benzylisoquinoline Alkaloid Biosynthesis in Coptis japonica

Kato, N., Dubouzet, E. G., Kokabu, Y., Yoshida, S., Taniguchi, Y., Dubouzet, J. G., Yazaki, K., & Sato, F. (2006) · Plant and Cell Physiology · doi:10.1093/pcp/pcl041 · Cited by 182 · see citing works

Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice

Yan, F., Wang, L., Shi, Y., Cao, H., Liu, L., Washington, M. K., Chaturvedi, R., Israel, D. A., Cao, H., Wang, B., et al. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00312.2011 · Cited by 182 · see citing works

Insulin Sensitizing and Insulinotropic Action of Berberine from Cortidis Rhizoma

Ko, B., Choi, S. B., Park, S. K., Jang, J. S., Kim, Y. E., & Park, S. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.1431 · Cited by 181 · see citing works

Molecular aspects on the interaction of protoberberine, benzophenanthridine, and aristolochia group of alkaloids with nucleic acid structures and biological perspectives

Maiti, M., & Kumar, G. S. (2006) · Medicinal Research Reviews · doi:10.1002/med.20087 · Cited by 180 · see citing works

Treatment for liver cancer: From sorafenib to natural products

Man, S., Luo, C., Yan, M., Zhao, G., Ma, L., & Gao, W. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113690 · Cited by 179 · see citing works

Effects and mechanisms of berberine in diabetes treatment

Yin, J., Ye, J., & Jia, W. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.06.003 · Cited by 183 · see citing works

Extracellular Signal-Regulated Kinase–Dependent Stabilization of Hepatic Low-Density Lipoprotein Receptor mRNA by Herbal Medicine Berberine

Abidi, P., Zhou, Y., Jiang, J., & Liu, J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000181761.16341.2b · Cited by 176 · see citing works

Pharmacological effects of berberine and its derivatives: a patent update

Jin, Y., Khadka, D. B., & Cho, W. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2016.1118060 · Cited by 174 · see citing works

A Natural Isoquinoline Alkaloid With Antitumor Activity: Studies of the Biological Activities of Berberine

Liu, D., Meng, X. W., Wu, D., Qiu, Z., & Luo, H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00009 · Cited by 174 · see citing works

Antiatherogenic properties of flavonoids: Implications for cardiovascular health

Mulvihill, E. E., & Huff, M. W. (2010) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(10)71056-4 · Cited by 172 · see citing works

Berberine – a novel approach to cholesterol lowering

Doggrell, S. A. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.5.683 · Cited by 72 · see citing works

Combination of simvastatin with berberine improves the lipid-lowering efficacy

Kong, W., Wei, J., Zuo, Z.-Y., Wang, Y., Song, D., You, X., Zhao, L., Pan, H.-N., & Jiang, J. (2008) · Metabolism · doi:10.1016/j.metabol.2008.01.037 · Cited by 162 · see citing works

Research on the effective improvement of hyperlipidemia by berberine

Wei, J. (2005) · Zhongguo tangniaobing zazhi · Cited by 10 · see citing works

Berberrubine and its analog, hydroxypropyl‐berberrubine, regulate LDLR and PCSK9 expression via the ERK signal pathway to exert cholesterol‐lowering effects in human hepatoma HepG2 cells

Cao, S., Xu, P., Yan, J., Liu, H., Liu, L., Cheng, L., Qiu, F., & Kang, N. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27102 · Cited by 56 · see citing works

Synthesis and structure–activity relationships of berberine analogues as a novel class of low-density-lipoprotein receptor up-regulators

Yang, P., Song, D., Li, Y., Kong, W., Wang, Y., Gao, L., Liu, S., Cao, R., & Jiang, J. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.005 · Cited by 64 · see citing works